» Articles » PMID: 10613909

Cofilin Phosphorylation and Actin Cytoskeletal Dynamics Regulated by Rho- and Cdc42-activated LIM-kinase 2

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 1999 Dec 30
PMID 10613909
Citations 147
Authors
Affiliations
Soon will be listed here.
Abstract

The rapid turnover of actin filaments and the tertiary meshwork formation are regulated by a variety of actin-binding proteins. Protein phosphorylation of cofilin, an actin-binding protein that depolymerizes actin filaments, suppresses its function. Thus, cofilin is a terminal effector of signaling cascades that evokes actin cytoskeletal rearrangement. When wild-type LIMK2 and kinase-dead LIMK2 (LIMK2/KD) were respectively expressed in cells, LIMK2, but not LIMK2/KD, phosphorylated cofilin and induced formation of stress fibers and focal complexes. LIMK2 activity toward cofilin phosphorylation was stimulated by coexpression of activated Rho and Cdc42, but not Rac. Importantly, expression of activated Rho and Cdc42, respectively, induced stress fibers and filopodia, whereas both Rho- induced stress fibers and Cdc42-induced filopodia were abrogated by the coexpression of LIMK2/KD. In contrast, the coexpression of LIMK2/KD with the activated Rac did not affect Rac-induced lamellipodia formation. These results indicate that LIMK2 plays a crucial role both in Rho- and Cdc42-induced actin cytoskeletal reorganization, at least in part by inhibiting the functions of cofilin. Together with recent findings that LIMK1 participates in Rac-induced lamellipodia formation, LIMK1 and LIMK2 function under control of distinct Rho subfamily GTPases and are essential regulators in the Rho subfamilies-induced actin cytoskeletal reorganization.

Citing Articles

LIM kinases in cardiovascular health and disease.

Lateef O, Foote C, Power G, Manrique-Acevedo C, Padilla J, Martinez-Lemus L Front Physiol. 2025; 15():1506356.

PMID: 39744707 PMC: 11688343. DOI: 10.3389/fphys.2024.1506356.


The Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy.

Quillen S, Kimball E, Ritter-Gordy K, Du L, Yuan Z, Pease M Invest Ophthalmol Vis Sci. 2024; 65(13):43.

PMID: 39565302 PMC: 11583991. DOI: 10.1167/iovs.65.13.43.


p57 Phosphorylation Modulates Its Localization, Stability, and Interactions.

Stampone E, Bencivenga D, Dassi L, Sarnelli S, Campagnolo L, Lacconi V Int J Mol Sci. 2024; 25(20).

PMID: 39456957 PMC: 11508627. DOI: 10.3390/ijms252011176.


Regulation and signaling of the LIM domain kinases.

Casanova-Sepulveda G, Boggon T Bioessays. 2024; 47(1):e2400184.

PMID: 39361252 PMC: 11663136. DOI: 10.1002/bies.202400184.


Sulfamoylated Estradiol Analogs Targeting the Actin and Microtubule Cytoskeletons Demonstrate Anti-Cancer Properties In Vitro and In Ovo.

Mercier A, Joubert A, Prudent R, Viallet J, Desroches-Castan A, De Koning L Cancers (Basel). 2024; 16(17).

PMID: 39272798 PMC: 11394244. DOI: 10.3390/cancers16172941.


References
1.
Ponting C, Phillips C, Davies K, Blake D . PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays. 1997; 19(6):469-79. DOI: 10.1002/bies.950190606. View

2.
Takai Y, Sasaki T, Tanaka K, Nakanishi H . Rho as a regulator of the cytoskeleton. Trends Biochem Sci. 1995; 20(6):227-31. DOI: 10.1016/s0968-0004(00)89022-2. View

3.
Mitchison T, Cramer L . Actin-based cell motility and cell locomotion. Cell. 1996; 84(3):371-9. DOI: 10.1016/s0092-8674(00)81281-7. View

4.
Ishizaki T, Maekawa M, Fujisawa K, Okawa K, Iwamatsu A, Fujita A . The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J. 1996; 15(8):1885-93. PMC: 450107. View

5.
Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M . Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 1996; 15(9):2208-16. PMC: 450144. View